Endoscopic retrograde cholangiopancreatography, endoscopic papillary balloon dilation, and laparoscopic hepatectomy for intra- and extrahepatic bile duct stones

Table 1 Comparative analysis of general information

Data	Control group (n = 55)	Observation group (n = 59)	χ2/t	P value
Sex, n (%)			0.477	0.490
Male	31 (56.36)	37 (62.71)
Female	24 (43.64)	22 (37.29)
Age (year)	64.36 ± 7.08	65.46 ± 6.65	0.855	0.394
Body mass (kg)	55.91 ± 7.01	58.07 ± 8.84	1.439	0.153
Disease course (year)	2.82 ± 0.88	2.93 ± 1.03	0.611	0.543
Time from onset to operation (day)	3.04 ± 0.86	3.14 ± 0.99	0.574	0.567

Table 2 Comparative analysis of curative effects, n (%)

Curative effect	Control group (n = 55)	Observation group (n = 59)	χ2	P value
Cured	16 (29.09)	23 (38.98)
Effective	23 (41.82)	30 (50.85)
Ineffective	16 (29.09)	6 (10.17)
Total effective rate	39 (70.91)	53 (89.83)	6.544	0.011

Table 3 Assignment of potential factors affecting the quality of life of patients with intra- and extrahepatic bile duct stones

Variable	Assignment
X1, gender	Female = 0, male = 1
X2, age (year)	< 65 = 0, ≥ 65 = 1
X3, body mass (kg)	< 55 = 0, ≥ 55 = 1
X4, disease course (year)	< 3 = 0, ≥ 3 = 1
X5, time from onset to operation (day)	< 3 = 0, ≥ 3 = 1
X6, treatment method	ERCP + EPBD + LH = 0, LCBDE plus hepatectomy = 1

ERCP: Endoscopic retrograde cholangiopancreatography; EPBD: Endoscopic papillary balloon dilation; LH: Laparoscopic hepatectomy; LCBDE: Laparoscopic common bile duct exploration.

Table 4 Logistic regression analysis of factors influencing the quality of life of patients with intra- and extrahepatic bile duct stones

Variable	β	SE	Wald	P value	Exp (β)	95%CI
Sex	-0.601	0.450	1.785	0.182	0.548	0.227-1.324
Age (year)	-0.643	0.425	2.288	0.130	0.526	0.229-1.209
Body mass (kg)	-0.327	0.428	0.585	0.444	0.721	0.311-1.668
Disease course (year)	-0.055	0.447	0.015	0.902	0.946	0.394-2.271
Time from disease onset to operation (day)	0.768	0.485	2.509	0.113	2.155	0.833-5.572
Therapeutic method	-1.227	0.427	8.244	0.004	0.293	0.127-0.677